Evolution of PTH assays

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 4, 2006, Pages 621-627

  Vieira, José Gilberto H ^a,b   Kunii, Ilda ^b   Nishida, Sônia ^a  

^a Fleury   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Circulating forms of parathyroid hormone; Immunometric assays; Parathyroid hormone assay; Radioimmunoassay

Indexed keywords

EID: 33751250788     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302006000400007     Document Type: Article

References (41)

1. Silverman R, Yalow RS. Heterogeneity of parathyroid hormone: clinical and physiologic implications. J Clin Invest 1973;52:1958-71.
2. D'Amour P, Palardy J, Bahsali G, Mallette LE, DeLéan A, Lepage R. The modulation of circulating parathyroid hormone immunoheterogeneity in man by ionized calcium concentration. J Clin Endocrinol Metab 1992;74:525-32.
3. Martin KJ, Hruska KA, Lewis J, Anderson C, Slatopolsky E. The renal handling of parathyroid hormone: role of peritubular uptake and glomerular filtration. J Clin Invest 1977;60:808-14.
4. Divieti P, Inomata N, Chapin K, Singh R, Jüppner H, Bringhurst FR. Receptors for carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells. Endocrinology 2001;142:916-25.
5. Divieti P, John MR, Jüppner H, Bringhurst FR. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 2002;143:171-6.
6. Divieti P, Geller AI, Suliman G, Jüppner H, Bringhurst FR. Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity. Endocrinology 2005;146:1863-70.
7. Berson SA, Yalow RS, Aurbach GD, Potts Jr JT. Immunoassay of bovine and human parathyroid hormone. Proc Natl Acad Sci USA 1963;49:613-6.
8. Reiss E, Canterbury JM. A radioimmunoassay for parathyroid hormone in man. Proc Soc Exp Biol Med 1968;128:501-4.
9. Arnaud CD, Tsao HS, Littledike T. Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest 1971;50:21-34.
10. Mallette L. Sensitivity of bovine parathyroid hormone serum 211/32 to synthetic fragments of human parathyroid hormone. J Clin Endocrinol Metab 1980;50:201-3.
11. Fischer JA, Binswanger U, Dietrich FM. Human parathyroid hormone. Immunological characterization of antibodies against a glandular extract and the synthetic fragments 1-12 and 1-34 and their use in the determination of immunoreactive hormone in human sera. J Clin Invest 1974;54:1382-94.
12. Manning RM, Hendy GN, Papapoulos SE, O'Riordan JLH. Development of homologous immunological assays for human parathyroid hormone. J Endocr 1980;85:161-70.
13. Simon M, Cuan J. C-terminal parathyrin (parathyroid hormone) radioimmunoassay in serum with commercially available reagents. Clin Chem 1980;26:1672-6.
14. Zanella MT, Silva MC, Pers RB, Ferreira SRG, Draibe SA, Vieira JGH. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure. Braz J Med Biol Res 1990;23:235-43.
15. Marx SJ, Sharp ME, Krudy A, Rosenblatt M, Mallette LE. Radioimmunoassay for the middle region of human parathyroid hormone: studies with radioiodinated synthetic peptides. J Clin Endocrinol Metab 1981;53:76-84.
16. Potts JT Jr, Tregear GW, Keutmann HT, Niall HD, Sauer R, Deftos LJ, et al. Synthesis of a biologically active N-terminal tetratriacontapeptide of parathyroid hormone. Proc Natl Acad Sci USA 1971;68:63-7.
17. Desplan C, Julienne A, Moukhtar MS, Milhaud G. Sensitive assay for biological active fragment of human parathyroid hormone. Lancet 1977;ii:198-9.
18. Visser TJ, Buurman CJ, Birkenhäger JC. Immunological studies of parathyroid hormone: characterization of antisera to the synthetic 1-34 human parathyroid hormone and evidence that position 30 is aspartic acid. J Endocr 1977;74:461-6.
19. Atkinson MJ, Jüpnner H, Niepel B, Casaretto M, Zahn H, Hesch RD. Characterization of binding sites of antiparathyroid hormone antisera using synthetic parathyroid hormone peptides. J Immunoassay 1982;3:31-51.
20. Vieira JGH, Oliveira MAD, Maciel RMB, Mesquita CH, Russo EMK. Development of an homologous radioimmunoassay for the synthetic amino terminal (1-34) fragment f human parathyroid hormone using egg yolk-obtained antibodies. J Immunoassay 1986;7:57-72.
21. Vieira JGH, Oliveira MAD, Hidal JT, Russo EMK, Chacra AR. Critical analysis of two segment-specific radioimmunoassays for the measurement of parathyroid hormone and their use in the diagnosis of primary hyperparathyroidism. Rev Ass Med Brasil 1988;34:79-83 (article in Portuguese).
22. Brandão CM, Kasamatsu TS, Oliveira MA, Vieira JG. Circulating molecular forms of parathyroid hormone in primary and secondary hyperparathyroidism. Braz J Med Biol Res 1989;22:963-5.
23. Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawa-Ung K, Kim L, et al. Highly sensitive two-site immunoradiometric assay of parathyrin and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987;33:1364-7.
24. Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone over-estimates the presence and severity of parathyroid mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992;75:143-50.
25. John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Jüppner H. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab 1999;84:4287-90.
26. Kunii IS, Vieira JGH. Circulating forms of parathyroid hormone detected with an immunofluorometric assay in patients with primary hyperparathyroidism and in hyperparathyroidism secondary to chronic renal failure. Braz J Med Biol Res 2001;34:1547-50.
27. Vieira JG, Nishida SK, Camargo MT, Obara LH, Kunii IS, Ohe MN, et al. PTH values obtained using immunometric assays depend on the specificity of the amino-terminal specific antibody used. Arq Bras Endocrinol Metab 2004;48:518-24 (article in Portuguese).
28. Vieira JGH, Nishida SK, Kasamatsu TS, Amarante EC, Kunii IS. Development and application of an immunofluorometric assay for intact parathyroid hormone. Braz J Med Biol Res 1994;27:2379-82.
29. Silverberg S, Gao P, Braown I, LoGerfo P, Cantor T, Bilezikian J. Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism. J Clin Endocrinol Metab 2003;88:4725-30.
30. Carnevale V, Dionisi S, Nofroni I, Romagnoli E, Paglia F, De Geronimo S, et al. Potential utility of a new IRMA for parathyroid hormone in post menopausal patients with primary hyperparathyroidism. Clin Chem 2004;50:626-31.
31. Boudou P, Ibrahim F, Cormier C, Chabas A, Sarfati E, Souberbielle J-C. Third or second generation parathyroid hormone assays: a remaining debate in the diagnosis of primary hyperparathyroidism. J Clin Endocrinol Metab 2005;90:6370-2.
32. Brossard J-H, Cloutier M, Roy L, Lepage R, Gascon-Barré M, D'Amour P. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab 1996;81:3923-9.
33. Lepage R, Roy L, Brossard J-H, Rousseau L, Dorais C, Lazure C, et al. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clin Chem 1998;44:805-9.
34. Monier-Faugere M-C, Geng Z, Mawad H, Friedler RM, Gao P, Cantor TL, et al. Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients. Kidney Int 2001;60:1460-8.
35. Coen G, Bonucci E, Ballanti P, Balducci A, Calabria S, Nicolai GA, et al. PTH 1-84 and PTH "7-84" in the noninvasive diagnosis of renal bone disease. Am J Kidney Dis 2002;40:348-54.
36. Salusky IB, Goodman WG, Kuizon BD, Lavigne JR, Zahranik RJ, Gales B, et al. Similar predictive value of bone turnover using first- and second generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis. Kidney Int 2003;63:1801-8.
37. Mallette LE. The parathyroid polyhormones: new concepts in the spectrum of peptide hormone action. Endocr Rev 1991;12:110-7.
38. D'Amour P, Brossard JH, Rousseau L, Nguyen-Yamamoto L, Nassif E, Lazure C, et al. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney Int 2005;68:998-1007.
39. Räkel A, Brossard J-H, Patenaude J-V, Albert C, Nassif E, Cantor T, et al. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery. Clin Endocrinol 2005;62:721-7.
40. D'Amour P, Brossard J-H, Räkel A, Rousseau L, Albert C, Cantor T. Evidence that the amino-terminal composition of non-(1-84) parathyroid hormone fragments starts before position 19. Clin Chem 2005;51:169-76.
41. Blumsohn A, Hadari AA. Parathyroid hormone: what are we measuring and does it matter? Ann Clin Biochem 2002;39:169-72.